208 related articles for article (PubMed ID: 35222744)
1. Serum and Cerebrospinal Fluid Testing in Optic Neuropathy Patients with Malignant Tumors.
Sun CB; Liu GH; Xiao Q; Zhao YN; Ren Q
Dis Markers; 2022; 2022():7076385. PubMed ID: 35222744
[TBL] [Abstract][Full Text] [Related]
2. Distinct clinical characteristics of paraneoplastic optic neuropathy.
Xu Q; Du W; Zhou H; Zhang X; Liu H; Song H; Wang X; Wei S
Br J Ophthalmol; 2019 Jun; 103(6):797-801. PubMed ID: 30021813
[TBL] [Abstract][Full Text] [Related]
3. CV2/CRMP5-antibody-related Paraneoplastic Optic Neuropathy Associated with Small-cell Lung Cancer.
Nakajima M; Uchibori A; Ogawa Y; Miyazaki T; Ichikawa Y; Kaneko K; Takahashi T; Nakashima I; Shiraishi H; Motomura M; Chiba A
Intern Med; 2018 Jun; 57(11):1645-1649. PubMed ID: 29321433
[TBL] [Abstract][Full Text] [Related]
4. [Optic neuropathy in positive anti-MOG antibody syndrome].
Merabtene L; Vignal Clermont C; Deschamps R
J Fr Ophtalmol; 2019 Dec; 42(10):1100-1110. PubMed ID: 31732265
[TBL] [Abstract][Full Text] [Related]
5. [Clinical characteristics of paraneoplastic retinopathy and optic neuropathy].
Huang HB; Wei SH; Li Y; Wang FX; Yao Y; Jiang CH; Yin ZQ; Zhang MN; Wei WB
Zhonghua Yan Ke Za Zhi; 2013 Jun; 49(6):507-13. PubMed ID: 24119963
[TBL] [Abstract][Full Text] [Related]
6. Paraneoplastic cerebellar syndromes associated with antibodies against Purkinje cells.
Schwenkenbecher P; Chacko L; Pul R; Sühs KW; Wegner F; Wurster U; Stangel M; Skripuletz T
Int J Neurosci; 2018 Aug; 128(8):721-728. PubMed ID: 29199513
[TBL] [Abstract][Full Text] [Related]
7. Paraneoplastic Optic Neuropathy Associated With Purkinje Cell Antibody-2 in a Patient With Small Cell Lung Cancer.
Micieli JA; Margolin EA
J Neuroophthalmol; 2017 Mar; 37(1):53-55. PubMed ID: 27759576
[TBL] [Abstract][Full Text] [Related]
8. Paraneoplastic optic neuropathy and cerebellar ataxia with small cell carcinoma of the lung.
Thambisetty MR; Scherzer CR; Yu Z; Lennon VA; Newman NJ
J Neuroophthalmol; 2001 Sep; 21(3):164-7. PubMed ID: 11725180
[TBL] [Abstract][Full Text] [Related]
9. [Paraneoplastic retinopathy and optic neuropathy].
Ikawa M; Kuriyama M
Brain Nerve; 2010 Apr; 62(4):371-6. PubMed ID: 20420177
[TBL] [Abstract][Full Text] [Related]
10. PARANEOPLASTIC OPTIC NEUROPATHY AS AN INITIAL CLINICAL MANIFESTATION OF SMALL CELL LUNG CANCER. A CASE REPORT.
Akbulut E; Bayraktar H; Tugcu B
Cesk Slov Oftalmol; 2021; 77(6):300-303. PubMed ID: 35081720
[TBL] [Abstract][Full Text] [Related]
11. CDR2 and CDR2L line blot performance in PCA-1/anti-Yo paraneoplastic autoimmunity.
Vorasoot N; Scharf M; Miske R; Thakolwiboon S; Dubey D; Mills JR; Pittock SJ; Zekeridou A; Ott A; McKeon A
Front Immunol; 2023; 14():1265797. PubMed ID: 37841252
[TBL] [Abstract][Full Text] [Related]
12. Detection of paraneoplastic antibodies and their significance in paraneoplastic neurologic syndromes: a narrative review.
Li L; Guo Y; Wang J
Ann Transl Med; 2023 Apr; 11(7):283. PubMed ID: 37090044
[TBL] [Abstract][Full Text] [Related]
13. Small cell lung carcinoma presenting as collapsin response-mediating protein (CRMP) -5 paraneoplastic optic neuropathy.
Sheorajpanday R; Slabbynck H; Van De Sompel W; Galdermans D; Neetens I; De Deyn PP
J Neuroophthalmol; 2006 Sep; 26(3):168-72. PubMed ID: 16966932
[TBL] [Abstract][Full Text] [Related]
14. Intrathecal synthesis of anti-Hu antibodies distinguishes patients with paraneoplastic peripheral neuropathy and encephalitis.
Schwenkenbecher P; Chacko LP; Wurster U; Pars K; Pul R; Sühs KW; Stangel M; Skripuletz T
BMC Neurol; 2016 Aug; 16(1):136. PubMed ID: 27515847
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and prognosis of myelin oligodendrocyte glycoprotein antibody-seropositive paediatric optic neuritis in China.
Song H; Zhou H; Yang M; Tan S; Wang J; Xu Q; Liu H; Wei S
Br J Ophthalmol; 2019 Jun; 103(6):831-836. PubMed ID: 30049802
[TBL] [Abstract][Full Text] [Related]
16. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients.
Gultekin SH; Rosenfeld MR; Voltz R; Eichen J; Posner JB; Dalmau J
Brain; 2000 Jul; 123 ( Pt 7)():1481-94. PubMed ID: 10869059
[TBL] [Abstract][Full Text] [Related]
17. Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration in a female patient with pleural malignant mesothelioma.
Tanriverdi O; Meydan N; Barutca S; Ozsan N; Gurel D; Veral A
Jpn J Clin Oncol; 2013 May; 43(5):563-8. PubMed ID: 23475537
[TBL] [Abstract][Full Text] [Related]
18. "Non-classical" paraneoplastic neurological syndromes associated with well-characterized antineuronal antibodies as compared to "classical" syndromes - More frequent than expected.
Berger B; Bischler P; Dersch R; Hottenrott T; Rauer S; Stich O
J Neurol Sci; 2015 May; 352(1-2):58-61. PubMed ID: 25824848
[TBL] [Abstract][Full Text] [Related]
19. Epidemiologic and Clinical Characteristics of Optic Neuritis in Japan.
Ishikawa H; Kezuka T; Shikishima K; Yamagami A; Hiraoka M; Chuman H; Nakamura M; Hoshi K; Goseki T; Mashimo K; Mimura O; Yoshitomi T; Tanaka K;
Ophthalmology; 2019 Oct; 126(10):1385-1398. PubMed ID: 31196727
[TBL] [Abstract][Full Text] [Related]
20. Accuracy of FDG-PET/CT and paraneoplastic antibodies in diagnosing cancer in paraneoplastic neurological syndromes.
Vatankulu B; Yilmaz Aksoy S; Asa S; Sager S; Sayman HB; Halac M; Sonmezoglu K
Rev Esp Med Nucl Imagen Mol; 2016; 35(1):17-21. PubMed ID: 26260889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
